February 5, 2020
Osaka-based biotech AnGes’ HGF gene therapy Collategene (beperminogene perplasmid) posted sales of 4 million yen in a period of some four months since its rollout on September 10, the company’s 2019 (January-December) earnings revealed. The gene therapy was granted conditional,...read more